SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-154295
Filing Date
2021-12-29
Accepted
2021-12-29 16:26:17
Documents
1
Period of Report
2021-12-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2136524-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2136524-1_4seq1.xml 4 5495
  Complete submission text file 0001104659-21-154295.txt   6940
Mailing Address 6 TIDE STREET BOSTON MA 02210
Business Address 6 TIDE STREET BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Issuer) CIK: 0001689375 (see all company filings)

IRS No.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AVROBIO, INC. ONE KENDALL SQ., BLDG. 300, STE. 201 CAMBRIDGE MA 02139
Business Address
KREHER NERISSA (Reporting) CIK: 0001741850 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40969 | Film No.: 211529144